Bicycle Therapeutics (BCYC)
(Delayed Data from NSDQ)
$25.41 USD
-0.09 (-0.35%)
Updated Sep 20, 2024 04:00 PM ET
2-Buy of 5 2
F Value D Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | -0.78 |
EPS Last Quarter | -0.77 |
Last EPS Surprise | 30.00% |
ABR | 1.46 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.18 |
Next Year | -3.42 |
EPS (TTM) | -3.81 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 8.16M | 7.25M | 44.30M | 39.96M |
# of Estimates | 6 | 6 | 6 | 6 |
High Estimate | 11.90M | 11.90M | 52.70M | 60.00M |
Low Estimate | 5.00M | 1.10M | 35.00M | 20.00M |
Year ago Sales | 5.35M | 5.33M | 26.98M | 44.30M |
Year over Year Growth Est. | 52.49% | 35.93% | 64.20% | -9.78% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.78 | -0.88 | -3.18 | -3.42 |
# of Estimates | 7 | 6 | 8 | 7 |
Most Recent Consensus | -0.86 | -0.89 | -3.18 | -3.67 |
High Estimate | -0.54 | -0.58 | -2.33 | -2.82 |
Low Estimate | -1.05 | -1.17 | -4.10 | -4.50 |
Year ago EPS | -1.26 | -1.16 | -5.08 | -3.18 |
Year over Year Growth Est. | 38.10% | 24.14% | 37.40% | -7.70% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 6 | 6 | 8 | 7 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.78 | -0.88 | -3.18 | -3.42 |
7 Days Ago | -0.78 | -0.88 | -3.18 | -3.42 |
30 Days Ago | -0.78 | -0.88 | -3.18 | -3.42 |
60 Days Ago | -1.20 | -1.32 | -4.44 | -5.01 |
90 Days Ago | -1.20 | -1.32 | -4.44 | -5.01 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.78 | -0.88 | -3.18 | -3.42 |
Zacks Consensus Estimate | -0.78 | -0.88 | -3.18 | -3.42 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.77 | -0.62 | -1.16 | -1.26 | NA |
Estimate | -1.10 | -1.26 | -1.23 | -1.06 | NA |
Difference | 0.33 | 0.64 | 0.07 | -0.20 | 0.21 |
Surprise | 30.00% | 50.79% | 5.69% | -18.87% | 16.90% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more